Trasylol and Arterial haemorrhage - a phase IV clinical study of FDA data

Summary:

Arterial haemorrhage is reported only by a few people who take Trasylol.

The phase IV clinical study analyzes which people take Trasylol and have Arterial haemorrhage. It is created by eHealthMe based on reports of 9,445 people who have side effects while taking Trasylol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 28, 2022

9,445 people reported to have side effects when taking Trasylol.
Among them, 2 people (0.02%) have Arterial haemorrhage.


What is Trasylol?

Trasylol has active ingredients of aprotinin. eHealthMe is studying from 9,445 Trasylol users for its effectiveness, alternative drugs and more.

What is Arterial haemorrhage?

Arterial haemorrhage is found to be associated with 470 drugs and 313 conditions by eHealthMe.

Number of Trasylol and Arterial haemorrhage reports submitted per year:

Could Trasylol cause Arterial haemorrhage?

Time on Trasylol when people have Arterial haemorrhage *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Arterial haemorrhage when taking Trasylol *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Arterial haemorrhage when taking Trasylol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Trasylol *:

  1. Vasopressin: 1 person, 50.00%
  2. Metoprolol Tartrate: 1 person, 50.00%
  3. Lasix: 1 person, 50.00%
  4. Heparin: 1 person, 50.00%
  5. Ancef: 1 person, 50.00%

Common side effects people have besides Arterial haemorrhage *:

  1. Mediastinal Haemorrhage (bleeding in mediastinum): 2 people, 100.00%
  2. Haemorrhage (bleeding): 2 people, 100.00%
  3. Pulmonary Thrombosis (scarring in the lungs): 1 person, 50.00%
  4. Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Trasylol and have Arterial haemorrhage?

Check whether Arterial haemorrhage is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Arterial haemorrhage and when was it recovered:

Expand to all the drugs that have ingredients of aprotinin:

Alternative drugs to, pros and cons of Trasylol:

Common Trasylol side effects:

Browse all side effects of Trasylol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Arterial haemorrhage treatments and more:

COVID vaccines that are related to Arterial haemorrhage:

Common drugs associated with Arterial haemorrhage:

All the drugs that are associated with Arterial haemorrhage:

Common conditions associated with Arterial haemorrhage:

All the conditions that are associated with Arterial haemorrhage:

How the study uses the data?

The study uses data from the FDA. It is based on aprotinin (the active ingredients of Trasylol) and Trasylol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: